| | | (S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosan-1-oic acid
CAS:1599440-25-1
BD01290795
95%
n/a (S)-12-Hydroxy-1,10-bis(2,4,6-triisopropylphenyl)-4,5,6,7-tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocine 12-oxide
CAS:1258276-28-6
BD634375
95%
MFCD31747036 (S)-2,6-Bis(3,5-di-tert-butyl-4-methoxyphenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
CAS:2757287-40-2
BD01411520
97%
n/a (S)-2-((2S,5S,8S,11S,14R)-14-AMINO-2,5,8-TRIS((R)-1-HYDROXYETHYL)-11-(HYDROXYMETHYL)-4,7,10,13-TETRAOXO-3,6,9,12-TETRAAZAPENTADECANAMIDO)-N1-((S)-1-(((2S,3R)-1-AMINO-3-HYDROXY-1-OXOBUTAN-2-YL)AMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPAN-2-YL)SUCCINAMIDE
CAS:106362-34-9
BD00822340
98%
MFCD00076838 (S)-2-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-8-((1H-Imidazol-5-yl)methyl)-2,20,26-tris(3-guanidinopropyl)-11-(hydroxymethyl)-5,17,29-triisobutyl-23-isopropyl-14-methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazadotriacontanamid
CAS:2828432-37-5
BD01317645
98%
n/a |
